Marcos Sintes, Syn2Psy ESR5, is one of the authors of a study recently posted as preprint on BioRxiv, on the potential effects of psilocybin for the therapy of autism spectrum disorder (ASD). The autors used valproic acid-exposed mice as a model of ASD and assessed the effects of the naturally occurring psychedelic prodrug psilocybin. They […]